Making optical biopsy a clinical reality in colonoscopy by East, J, Rees, C

Sport and social theory / by Rees, C. Roger, Miracle, Andrew W.

Isolation of parietal cells from guinea-pig gastric mucosa and the immunological characterization of their antigenic structure. by Jewell, D, Katiyar, V, Rees, C, Taylor, K, Wright, J

Tetracycline resistance mediated by tet(M) has variable integrative conjugative element composition in mycoplasma hominis isolated in the United Kingdom from 2005-2015 by Chalker, VJ, Sharratt, MG, Rees, C, Bell, OH, Portal, E, Sands, K, Payne, MS, Spiller, OB

British Society of Gastroenterology position statement on serrated polyps in the colon and rectum by East, J, Atkin, W, Bateman, A, Clark, S, Dolwani, S, Ket, S, Leedham, S, Phull, P, Rutter, M, Shepherd, N, Tomlinson, I, Rees, C

OC-024 Detect inspect characterise resect and discard 2: are we ready to dispense with histology? by Rajasekhar, P, Mason, J, Wilson, A, Close, H, Rutter, M, Saunders, B, East, J, Maier, R, Moorghen, M, Rees, C

Impaired cellular and humoral immunity is a feature of Diamond‐Blackfan anaemia; experience of 107 unselected cases in the United Kingdom by Iskander, D, Roberts, I, Rees, C, Szyldo, R, Alikian, M, Neale, M, Harrington, Y, Kelleher, P, Karadimitris, A, Fuente, JDL

British society of gastroenterology Endoscopy Quality Improvement Programme (EQIP): overview and progress by Rees, C, Koo, S, Anderson, J, McAlindon, M, Veitch, A, Morris, A, Bhandari, P, East, J, Webster, G, Oppong, K, Penman, I

Narrow band imaging optical diagnosis of small colorectal polyps in routine clinical practice: the Detect Inspect Characterise Resect and Discard 2 (DISCARD 2) study by Rees, C, Rajasekhar, P, Wilson, A, Close, H, Rutter, MD, Saunders, B, East, J, Maier, R, Moorghen, M, Muhammad, U, Hancock, H, Jayaprakash, A, MacDonald, C, Ramadas, A, Dhar, A, Mason, J

Trajectories of interferon-gamma release assay results over two years in independent cohorts from China, South Africa, Tanzania, and the United States by Chen, C, Xue, H, Horsburgh, CR, Amour, M, Hatherill, M, Tameris, M, von Reyn, CF, Rees, C, Shen, Y, McShane, H, García-Basteiro, AL, Liu, D, Wang, Y, Nathavitharana, RR, Graviss, EA, Shao, Y, Liu, Q, Lu, W, Zhu, L, Martinez, L

Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study by Pugh, SA, Bowers, M, Ball, A, Falk, S, Finch-Jones, M, Valle, JW, O'Reilly, DA, Siriwardena, AK, Hornbuckle, J, Rees, M, Rees, C, Iveson, T, Hickish, T, Maishman, T, Stanton, L, Dixon, E, Corkhill, A, Radford, M, Garden, OJ, Cunningham, D, Maughan, TS, Bridgewater, JA, Primrose, JN

Urgent improvements needed to diagnose and manage Lynch syndrome. by Monahan, K, Alsina, D, Bach, S, Buchanan, J, Burn, J, Clark, S, Dawson, P, De Souza, B, Din, F, Dolwani, S, Dunlop, M, East, J, Evans, D, Fearnhead, N, Frayling, I, Glynne-Jones, R, Hill, J, Houlston, R, Hull, M, Lalloo, F, Latchford, A, Lishman, S, Quirke, P, Rees, C, Rutter, M, Sasieni, P, Senapati, A, Speake, D, Thomas, H, Tomlinson, I

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative by Kaminski, M, Thomas-Gibson, S, Bugajski, M, Bretthauer, M, Rees, C, Dekker, E, Hoff, G, Jover, R, Suchanek, S, Ferlitsch, M, Anderson, J, Roesch, T, Hultcranz, R, Racz, I, Kuipers, E, Garborg, K, East, J, Rupinski, M, Seip, B, Bennett, C, Senore, C, Minozzi, S, Bisschops, R, Domagk, D, Valori, R, Spada, C, Hassan, C, Dinis-Ribeiro, M, Rutter, M

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative by Kaminski, M, Thomas-Gibson, S, Bugajski, M, Bretthauer, M, Rees, C, Dekker, E, Hoff, G, Jover, R, Suchanek, S, Ferlitsch, M, Anderson, J, Roesch, T, Hultcranz, R, Racz, I, Kuipers, E, Garborg, K, East, J, Rupinski, M, Seip, B, Bennett, C, Senore, C, Minozzi, S, Bisschops, R, Domagk, D, Valori, R, Spada, C, Hassan, C, Dinis-Ribeiro, M, Rutter, M

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial by Iveson, T, Kerr, R, Saunders, M, Cassidy, J, Hollander, N, Tabernero, J, Haydon, A, Glimelius, B, Harkin, A, Allan, K, McQueen, J, Scudder, C, Boyd, K, Briggs, A, Waterston, A, Medley, L, Wilson, C, Ellis, R, Essapen, S, Dhadda, A, Harrison, M, Falk, S, Raouf, S, Rees, C, Olesen, R, Propper, D, Bridgewater, J, Azzabi, A, Farrugia, D, Webb, A, Cunningham, D, Hickish, T, Weaver, A, Gollins, S, Wasan, H, Paul, J